News Industry News STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions July 28, 2017
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Industry News STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes May 25, 2017